Two Directors at Bangkok Dusit Medical Services Public Company Limited bought 10,786,000 shares at between 18.860THB and 19.000THB. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tra...
Greater China Economics | Money Supply M1 growth fell to 6.2% yoy in October, short of expectations, while M2 growth eased to 8.2% yoy. New bank loans dropped sharply to Rmb0.22t, and new TSF fell to Rmb0.81t, both below forecasts. Outstanding TSF and bank loan growth moderated to 8.5% (-0.2ppt mom) and 6.5% yoy (-0.1ppt mom) respectively, with the decline led by household loans. The numbers are not encouraging. Sector Update | Automobile China’s PV retail sales basically remained flat yoy in O...
Company Update | Bangkok Dusit Medical Services (BDMS TB/BUY/Bt19.70/Target: Bt32.00) The tone at BDMS’ analyst meeting tone was positive, with management maintaining a strong outlook for 4Q25 supported by the ongoing influenza outbreak. Influenza cases surged 44.9% yoy in Week 45, boosting Thai patient revenue by 8% yoy in Oct 25. 3Q25 net profit came in at Bt4.3b (+1.7% yoy), beating consensus by 5%. While the Ministry of Commerce’s new measure may slightly affect top-line, BDMS plans to mitig...
Top Stories Company Results | AP (Thailand) (AP TB/BUY/Bt7.90/Target: Bt9.30) AP posted a net profit of Bt1.15b in 3Q25 (-20% yoy, +15% qoq), in line with our estimate. The qoq improvement was underpinned by a solid performance in the low-rise segment, improved gross margin and higher equity income. AP revised down its 2025 launch plan from Bt65.0b to Bt59.6b. However, we are optimistic about the presales and earnings outlook for 4Q25. We still like AP as the market leader with a more aggressi...
Company Update | Bangkok Dusit Medical Services (BDMS TB/BUY/Bt20.20/Target: Bt32.00) BDMS is expected to post 3Q25 net profit of Bt4.19b (-1.2% yoy, +20.2% qoq), with mild topline growth to Bt28.5b, supported by strong epidemic-related cases in Sep 25 but offset by a high base last year and weaker Cambodian revenue. The ongoing flu outbreak, up 18.3% yoy, should extend benefits into 4Q25, boosting Thai patient volume. The new Ministry of Commerce measure should have minimal (
Top Stories Sector Update | Electronics We expect the combined 3Q25 core profit of Thai electronic stocks under our coverage to decline 13% yoy, pressured by lower gross margins from baht appreciation, but to increase 18% qoq, supported by higher revenue and margin improvement. We upgrade the sector to MARKET WEIGHT with KCE as our top pick, as geopolitical uncertainty has eased; however, we expect the recovery to be gradual, as the sector will likely remain under pressure from the strong bah...
Greater China Sector Update | Property Jinling Residence’s strong sell-out highlights resilient end-user demand despite weaker investment sentiment, while major cities’ October data showed yoy declines in both new and secondary home sales. We maintain MARKET WEIGHT. We upgrade Kerry Properties to BUY after the recent correction, with an unchanged target price of HK$22.80. Company Update | Alibaba Group (9988 HK/BUY/HK$155.20/Target: HK$203.00) We expect solid 2QFY26 results, despite marg...
Greater China Sector Update | Automobile China’s PV sales rebounded last week, with PEV growth surging from below 5% to over 30% due to subsidies and new models. Geely and XPeng led, while BYD and Li Auto lagged. Vehicle exports rose 26% yoy in August, driven by gains in the EU, Africa, and Middle East. Maintain MARKET WEIGHT. Top BUYs: CATL (target price raised to Rmb520) and Geely. Top SELLs: BYD and Li Auto. Sector Update | Healthcare Falling interest rates are expected to significant...
The tone at BDMS’ 2Q25 analyst meeting was neutral. Management revised down its 2025 revenue growth target further to 3-5% yoy to reflect the current ongoing conflict between Thailand and Cambodia. The outlook in 3Q25 is quite challenging as Jul 25 was not a good month for BDMS. Last year’s earnings base was high from the epidemic, and the conflict has yet to die down. However, we still prefer BDMS as a long-term pick. Maintain BUY. Target price: Bt32.00.
KEY HIGHLIGHTS Results COM7 (COM7 TB/BUY/Bt24.50/Target: Bt29.50) 2Q25: Better-than-expected earnings. Electricity Generating (EGCO TB/BUY/Bt113.00/Target: Bt125.00) 2Q25: Results beat expectations, with yield remaining impressive. GFPT (GFPT TB/BUY/Bt10.10/Target: Bt15.50) 2Q25: Earnings beat expectations on solid profitability. Hana Microelectronics (HANA TB/HOLD/Bt22.60/Target: Bt20.00) ...
GREATER CHINA Sector Automobile Weekly: Yoy growth of China’s PEV sales turns negative; lithium price recovers. Maintain MARKET WEIGHT on the sector. Top BUYs: CATL, Geely and Tuopu. Results Geely Auto (175 HK/BUY/HK$18.95/Target: HK$42.00) 2Q25: Core earnings surge 93% yoy, in line; raise target price to HK$42.00. Maintain BUY. Hysan Development (14 HK/BUY/HK$15.67/Target: HK$17.84) ...
BDMS reported a net profit of Bt3.5b in 2Q25 (+4.6% yoy, -19.7% qoq) which is in line with our forecast and the consensus. The top-line came in at Bt26.7b (+4.0% yoy, -4.8% qoq), with main contributions from a mild revenue growth from Thai patients of 3% yoy and strong revenue growth from international patients of 6% yoy. The strong growth from key nations were able to offset a slowdown from the latest Thai-Cambodia conflict. Maintain BUY. Target price: Bt32.00.
GREATER CHINA Economics Money Supply Credit demand remains weak, though money supply improved. Results Nexteer Automotive Group (1316 HK/BUY/HK$6.92/Target: HK$10.00) 1H25: Earnings beat estimates on margins. Upgrade from HOLD to BUY. Raise target price to HK$10.00 Tencent Holdings (700 HK/BUY/HK$586.00/Target: HK$736.00) 2Q25: Resilient results; unfolding AI monetisation in online games...
We expect BDMS to report a net profit of Bt3.4b in 2Q25 (+2.1% yoy). The top-line should be at Bt26.9b (+4.7% yoy, -4.2% qoq), with main contributions from a modest revenue growth from Thai patients and a robust growth from foreign patient arrivals especially due to a strong rebound in Middle East patient arrivals. The latest Thai-Cambodia conflict is causing some slowdown in Cambodian patient arrivals, but we expect it to be only a short-term issue. Maintain BUY. Target price: Bt32.00.
KEY HIGHLIGHTS Results TISCO Financial Group (TISCO TB/HOLD/Bt99.00/Target: Bt96.00) 2Q25: Results in line with consensus; impact from "You Fight We Help" measure should be mostly reflected. Update Bangkok Dusit Medical Services (BDMS TB/BUY/Bt20.60/Target: Bt32.00) Expect mild 2Q25 earnings growth. SCGP (SCGP TB/BUY/Bt17.30/Target: Bt21.00) 2Q25 net profit expected to recover qoq, with 2H25 net profit likely to surpass 1H25.
GREATER CHINA Economics Economic Activity Resilient 1H25 growth of 5.3% yoy belies rising downside pressure. Sector Healthcare Weekly: Gaining strength on robust earnings outlook and pipeline growth. Maintain OVERWEIGHT. Property Property sales and prices weakened further in J...
GREATER CHINA Economics PMI Modest recovery with construction rebound. Sector Macau Gaming Jun 25 GGR beat consensus by 9%; GGR has regained momentum in recent months. INDONESIA Small/Mid Cap Highlights MAP Aktif Adiperkasa (MAPA IJ/NOT RATED/Rp700) Expanding active lifestyle retail business; 1Q25 NPAT up 21% yoy. MAL...
We went to visit BDMS’ hospitals in Phuket and the newly-opened oncology centre. We see a very dominating network expansion by BDMS with a market share of over 85% in Phuket. With the upcoming competition from new hospitals, we believe that BDMS will be able to maintain its strong position given its location advantage and capability in providing up to tertiary care in Phuket. BDMS firmly remains as our top pick in the healthcare sector. Maintain BUY. Target price: Bt32.00.
GREATER CHINA Sector Insurance Weighing the risks and returns. Update Sunny Optical (2382 HK/BUY/HK$65.15/Target: HK$100.00) Takeaways from 2025 Investor Day. Maintain BUY. INDONESIA Strategy Challenging Macro Environment Adds To Case For Rate Cut Our top picks are BBCA, BBRI, ANTM, AMRT, ICBP, CMRY and ERAA. MALAYSIA Sector Automobile ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.